Navigation Links
ViroPharma Incorporated Reports Fourth Quarter and Full Year 2010 Financial Results
Date:2/24/2011

opean approval in the first half of 2011.  Additionally, our work will accelerate in 2011 toward expanding the use of C1 esterase inhibitor into other complement-mediated diseases."

The Company is reporting both GAAP net income (loss) and non-GAAP adjusted results for the three and twelve months ended December 31, 2010 and 2009.  Non-GAAP adjusted net income is GAAP net income excluding (1) non-cash interest expense, (2) amortization related intangible assets acquired, and step up in inventory related to purchase accounting, (3) stock compensation expenses, and (4) certain non-recurring events such as the goodwill write off, impairment loss and gain on extinguishment of repurchased bonds.  A reconciliation between GAAP and non-GAAP adjusted net income is provided in the Selected Financial Information - Reconciliation of GAAP Net Income (loss) to non-GAAP adjusted Net Income table included with this release.

The Company believes it is important to share these non-GAAP financial measures with shareholders as they better represent the ongoing economics of the business and reflect how we manage the business.  Accordingly, management believes investors' understanding of the Company's financial performance is enhanced as a result of our disclosing these non-GAAP financial measures. Non-GAAP adjusted net income should not be viewed in isolation, or as a substitute for or superior to reported GAAP net income (loss). ViroPharma's definition of non-GAAP financial measures may differ from others.

Non-GAAP adjusted net income in the three and twelve months ended December 31, 2010 was $45.6 million and $156.9 million, respectively, compared to $20.8 million and $83.6 million, respectively, for the same periods in 2009.  The increase in adjusted net income for both periods is primarily due to the net effect of the Cinryze launch and lower research and development expenses, partly offset by increased cost of sales due to the increase
'/>"/>

SOURCE ViroPharma Incorporated
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. ViroPharma to Present at Three September Healthcare Conferences
2. ViroPharma to Present at Three October Healthcare Conferences
3. ViroPharma to Release 2008 Third Quarter Financial Results on October 29, 2008
4. ViroPharma Enhances Leadership to Support Global Growth and Expanding Business
5. ViroPharma to Present at Three November Healthcare Conferences
6. ViroPharma Incorporated Reports Fourth Quarter and Full Year 2008 Financial Results
7. ViroPharma Improves Financial Position Through Repurchase of $45 Million Principal Amount of Senior Convertible Notes
8. ViroPharma to Release 2009 First Quarter Financial Results on April 29, 2009
9. ViroPharma Incorporated Reports First Quarter 2009 Financial Results
10. ViroPharma Incorporated Honored by the National Organization for Rare Disorders
11. ViroPharma to Present at Two June Healthcare Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2013)... Cambridge Healthtech Institute will host its fifth ... the Renaissance Waterfront Hotel in Boston, MA. The ... at the current strategies and innovations for optimizing bioprocesses ... in the field will reveal how their work has ... specificity and efficiency. , “In this age of rapid ...
(Date:5/16/2013)... DIEGO , May 16, 2013  The registration ... of Bioscience Financial Officers (ABFO) 2013 National Conference, the ... be held May 28-31 at the Hilton San Diego ... touches on this year,s conference and want to make ... to attend," said Brandi Roberts , ...
(Date:5/16/2013)... On average, developing a new drug ... dollars. Despite this investment, less than 10% of drugs ... your clinical trial design optimally structured to balance time, ... Dr. Frederic Sax, Global Head of the Center for ... data, information and technology in upfront clinical trial planning ...
(Date:5/16/2013)... VA (PRWEB) May 16, 2013 BioInformatics ... Primary Cells & Stem Cell-Derived Cells: Current and Future ... the number of suppliers in the primary cells market ... what cell types are used most often, how satisfied ... the market size and anticipated growth rate. , ...
Breaking Biology Technology:The 2013 Bioprocessing Summit to Bring Together International Leaders to Discuss Today's Bioprocess Issues From Cell Line Selection to Manufacturing in Boston, MA 2Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 2Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 3Registration Extended Until May 22 for Association of Bioscience Financial Officers (ABFO) 2013 National Conference -- San Diego 4Optimizing Clinical Trials Outcomes through Computer Assisted Design, New Life Science Webinar Hosted by Xtalks 2BioInformatics LLC New Market Report – The Market for Primary Cells & Stem Cell-Derived Cells: Current and Future Opportunities (13-004) 2BioInformatics LLC New Market Report – The Market for Primary Cells & Stem Cell-Derived Cells: Current and Future Opportunities (13-004) 3
... energy crisis? Probably not, but a hamster wearing ... to provide a new and renewable source of electricity. ... Technology researchers have also generated electrical current from a ... cell phones and other handhelds one step closer to ...
... by GeneSeek Inc.LINCOLN, Neb., Feb. 13 A ... medical-grade source pigs which are being developed by ... pig islet cells for transplantation to cure diabetes. ... laboratory and global leader in contractual high-throughput genotyping, ...
... TAIAN CITY, Shandong, China, Feb. 13 /PRNewswire-Asia-FirstCall/ -- ... Biologic" or the,"Company"), one of the leading plasma-based ... today announced that one of its R&D,projects, "High-Purity ... Torch,Plan of China. , ...
Cached Biology Technology:Nanogenerators produce electricity from running rodents and tapping fingers 2Nanogenerators produce electricity from running rodents and tapping fingers 3Pigs to Be Genotyped to Improve Selection and Breeding for Pancreatic Islet Cell Research 2Pigs to Be Genotyped to Improve Selection and Breeding for Pancreatic Islet Cell Research 3China Biologic Products' High-Purity Human Albumin Research and Development Project to be Listed in the National Torch Plan 2China Biologic Products' High-Purity Human Albumin Research and Development Project to be Listed in the National Torch Plan 3
(Date:5/16/2013)... an ancient extinct creature with ,scissor hand-like, claws in ... his favourite movie star. , The 505 million ... Koo-ten-ee-che-la depp-eye), which is a distant ancestor of lobsters ... for his starring role as Edward Scissorhands - a ... creation, who has scissors for hands. , ...
(Date:5/16/2013)... Canada and around the world are meeting next ... Meeting will showcase the latest in research findings ... clues to understanding the disorders that affect them., ... this meeting will showcase the best of neuroscience ... Sam David, President of the Canadian Association for ...
(Date:5/16/2013)... , May 16, 2013 The ... Award on Tuesday to Germany,s ... biometric border control system. DERMALOG has been ... Best Practices Award in the category Global Biometrics and ... edge Biometric   Border Control System . One ...
Breaking Biology News(10 mins):Actor Johnny Depp immortalized in ancient fossil find 27th Annual Canadian Neuroscience Meeting, Toronto, May 20-24, 2013 2Global Biometrics and Border Control Award for DERMALOG 2Global Biometrics and Border Control Award for DERMALOG 3Global Biometrics and Border Control Award for DERMALOG 4
... in the open access journal PLoS Biology, researchers ... result that the survival of juvenile salmon in two ... an extensive network of dams in one river system., ... such as sharks, sturgeon, tuna and sea turtles, and to ...
... This release is available in French . ... a $100,000 grant from the Gates Foundation to help ... Africa. "People are always asking why the ... of the poor, like parasitic infections," said Dr. Timothy ...
... more important carriers of avian influenza viruses from continent ... research that has important implications for highly pathogenic avian ... of a multi-pronged research effort to understand the role ... viruses between Asia and North America, scientists with the ...
Cached Biology News:Research challenges conventional notions about salmon survival 2Boost from McGill, Gates Foundation helps Africans control pharma research 2Genetic evidence for avian influenza movement from Asia to North America via wild birds 2
... LC micro-fractionation, spotting and preparation for ... LC eluent can be accurately and ... trace amounts. This allows for automatic ... measurements. When used in conjunction with ...
... Sigmas 10 Capillary Electrophoresis Running Buffer was ... high throughput demands of todays sequencing labs. ... of TBE to the gel-based sequencing community ... scale capacity to meet your buffer needs. ...
... far-infrared range FT-IR spectrometers give you the ... Yet all this comes at an amazingly ... Having a larger and faster mirror closer ... FT-IRs provides 300%,larger solid angle of energy ...
... The CEQ 8800 Genetic Analysis System, which ... This automated system adds a higher level ... The CEQ 8800, part of Beckman Coulters new ... coding link with the Biomek series liquid handers, ...
Biology Products: